Treating generalised anxiety disorder
- PMID: 12663409
- PMCID: PMC1125601
- DOI: 10.1136/bmj.326.7391.700
Treating generalised anxiety disorder
Comment in
-
Commentary: Putting research into practice.BMJ. 2003 Mar 29;326(7391):700-2; discussion 700-2. BMJ. 2003. PMID: 12664889 No abstract available.
-
Commentary: A patient's story of living with anxiety.BMJ. 2003 Mar 29;326(7391):700-2; discussion 700-2. BMJ. 2003. PMID: 12664890 No abstract available.
References
-
- Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the national comorbidity survey. Arch Gen Psychiatry. 1994;51:8–19. - PubMed
-
- Ninan PT. Dissolving the burden of generalized anxiety disorder. J Clin Psychiatry. 2001;62(suppl 19):5–10. - PubMed
-
- Wittchen HU, Hoyer J. Generalized anxiety disorder: nature and course. J Clin Psychiatry. 2001;62(suppl 11):15–19. ; discussion 20-1. - PubMed
-
- Gould RA, Otto MW, Pollack MH, Yap L. Cognitive behavioural and pharmacological treatment of generalised anxiety disorder: a preliminary meta-analysis. Behav Res Ther. 1997;28:285–305.
-
- Rickels K, DeMartinis N, Aufdembrinke B. A double-blind, placebo controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder. J Clin Psychopharmacol. 2000;20:12–18. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical